KPW
ABEO icon

Kore Private Wealth’s Abeona Therapeutics ABEO Stock Holding History

Kore Private Wealth’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-6,185
Closed -$32K – 264
2022
Q2 		$32K Hold
6,185
– – ﹤0.01% 305
2022
Q1 		$49K Hold
6,185
– – 0.01% 315
2021
Q4 		$52K Buy
6,185
+4,903
+382% +$90.1K 0.01% 301
2021
Q3 		$36K Sell
1,282
-1,816
-59% -$58.1K ﹤0.01% 444
2021
Q2 		$121K Buy
+3,098
New +$126K 0.01% 404
2019
Q1 		– Sell
-40
Closed -$7K – 894
2018
Q4 		$7K Buy
+40
New +$8.72K ﹤0.01% 615

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kore Private Wealth's ABEO Position: Q3 2022 in Review

Kore Private Wealth sold out of Abeona Therapeutics (ABEO) in Q3 2022, closing a stake of 6,185 shares — an estimated $32K sold.

Kore Private Wealth first reported a position in ABEO in Q4 2018 and held it in 6 quarters. The position peaked at $121K in Q2 2021. 24 funds tracked by Wall St. Rank hold ABEO as of Q3 2022.

  • Kore Private Wealth reported no remaining Abeona Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Kore Private Wealth sold 6,185 Abeona Therapeutics shares in Q3 2022, an estimated $32K.
  • Kore Private Wealth first reported a position in Abeona Therapeutics in Q4 2018 and held it in 6 quarters.
  • Kore Private Wealth's Abeona Therapeutics position peaked at $121K in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2022.

Based on Kore Private Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.